新型重组人血小板衍化生长因子B腺病毒载体的构建与转染牙周干细胞的研究

目的 构建人血小板衍化生长因子B(platelet-derived growth factor-B,PDGF-B)重组复制缺陷型腺病毒载体,使其感染牙周韧带干细胞(periodontal ligament stem cells,PDLSC)并检测其相关生物学变化.方法 采用常规分子生物学方法,构建重组穿梭载体PAdTraekCMV-PDGF-B,用Pine I酶线性化后,线性化质粒在细菌BJ5183内与腺病毒骨架载体质粒AdEasy I同源重组,构建重组腺病毒质粒pAd-PDGF-B,在HEK293细胞中包装成重组腺病毒Ad-PDGF-B.Western blotting法检测其在HEK293中的表达情况,同时利用包装好的病毒感染PDLSC,用免疫组化的方法鉴定PDGF-B在细胞中的表达;采用甲基噻唑基四唑(MTr)法检测感染病毒后PDLSC的增殖变化,用反转录聚合酶链反应(RT-PCR)检测感染后细胞分泌I型胶原的变化.结果 重组缺陷型腺病毒载体经限制性内切酶酶切分析鉴定,与预期结果一致.重组质粒转染HEK293细胞3 d后即可观察到绿色荧光蛋白(green fluorescence protein,GFP)明显表达,Western blotting检测证实PDGF-B表达.重组病毒能够感染PDLSC并表达蛋白,MTT结果显示感染Ad-PDGF-B后的PDLSC增殖能力明显加强.在感染后第4天,感染Ad-PDGF-B后的PDLSC组吸光度值为(0.68±0.02),与对照组相比差异有统计学意义(P＜0.01).同时I型胶原表达量增高.结论 利用新型腺病毒载体AdEasy系统可快速构建同时表达EGFP和PDGF-B的重组复制缺陷型腺病毒Ad-PDGF-B,此病毒能够感染PDLSC并促进其增殖,同时增强I型胶原的表达,为牙周病患者牙周组织再生和种植体周韧带重建的基因治疗奠定基础.     

牙龈卟啉单胞菌对脐静脉血管内皮细胞产生sICAM-1的影响

目的：观察牙龈卟啉单胞菌（Porphyromonas gingivalis,P.gingivalis)对人类脐静脉血管内皮细胞（human umbilical vein endothelial cells,HUVECs)产生可溶性细胞间粘附分子－1（soluble intercellular adhesion molecule-1,sICAM-1)的影响。方法：应用厌氧袋法培养P.gingivalis，并用其感染HUVECs，采和酶联免疫吸附实验（enzyme-linked immunosorbent assay,ELISA)测定培养上清中sICAM-1的含量，结果：HUVECs基础表达少量的sICAM-1;P.gingivalis剂量依赖性增强HUVECs产生sICAM-1蛋白的水平；紫外线、超声波和65℃的热处理都不能抑制P.gingivalis的作用；sICAM-1蛋白水平在P.gingivalis刺激后的4h未见改变，增高的作用从刺激后的8h开始，在12h,16h和20h继续增加。结论：活的和灭活的P.gingivalis都剂量依赖性和时间依赖性地增强HUVECs产生sICAM-1,P.gingivalis可能同样诱导牙龈血管内皮细胞表达sICAM-1，升高的sICAM-1可能参与调节牙周病炎症反应和免疫反应过程。     

p38 MAPK在LPS诱导牙龈成纤维细胞表达uPA中作用的研究

目的：研究p38 MAPK在LPS诱导牙龈成纤维细胞表达uPA中的作用。方法：采用Western blotting观察LPS对牙龈成纤维细胞内p38 MAPK活性的影响；蛋白激酶活性实验SB203580地p38 MAPK活性的抑制作用；Northern blotting观察SB203580对LPS诱导uPA表达的影响。结果：LPS能够迅速地激活牙龈成纤维细胞内p38 MAPK的活性；SB203580能够有效地抑制牙龈成纤维细胞内的p38 MAPK的活性；经SB203580处理后，LPS对uPA的诱导作用受到显著的抑制。结论：LPS通过p38 MAPK信号转导途径诱导牙龈成纤维细胞表达uPA。     

The fibrous structure of the cemento-dentinal junction in human molars shown by scanning electron microscopy combined with NaOH-maceration

The cemento dentinal junction was studied in acellular and cellular cementum of human mandibular third molars by scanning electron microscopy combined with NaOH-maceration. Scanning electron microscopy with NaOH-maceration was applied to observe the fibrous structure in detail through long sections of the cemento-dentinal junction. In macerated specimens, the cemento dentinal junction was a fibril-poor groove. Some cemental fibrils or fibril bundles penetrated the groove and appeared to intermingle with dentinal fibrils. Prolonged maceration caused detachment of the cemento-dentinal junction irrespective of fibril intermingling allowing observation of the inner cementum surface facing the root dentin. Observations suggested that the fibril intermingling was point-like and present only in places at the cemento-dentinal junction. It was established that NaOH-maceration removes interfibrillar substances effectively in connective tissues and does no damage to the collagen fibril structure and architecture. This study showed the 3-dimensional fibrous structure of the cemento-dentinal junction in human mandibular third molars, and suggested that interfibrillar adhesive substances are more important than the fibril intermingling for the cemento-dentinal attachment.     

人牙周膜成纤维细胞在无血清培养液中的生长特性

目的：探讨人牙周膜成纤维细胞在无血清培养液中的生长特性。方法：用倒置显微镜和MTT法观察人牙周膜成纤维细胞在无血清培养液中的生长和增殖变化。结果：人牙周膜成纤维细胞在无血清培养条件下可以生长的增殖，但与含血清培养液相比，其增殖速率变缓，分化明显。结论：无血清培养液可应用于人牙周膜成纤维细胞的体外培养和实验研究中。     

Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts

The relative distribution of urokinase-type plasminogen activator (u-PA), tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1) and plasminogen activator inhibitor-2 (PAI-2) was studied in cultured human gingival fibroblasts, healthy gingival tissues and inflamed gingival tissues by immunohistochemistry. In cultured gingival fibroblasts t-PA, u-PA and PAI-1 were expressed in cytoplasm; u-PA and PAI-1 were more intensely stained than t-PA; PAI-2 was not detectable in gingival fibroblasts. Following interleukin 1β (IL-1β) stimulation, the intensity of intracellular staining for t-PA was increased and a number of cells staining strongly for PAI-2 were seen; no difference in the intensity of immunostaining level was noted for the expression of u-PA and PAI-1 between IL-1β stimulated cells and unstimulated cells. In healthy gingival tissues, u-PA and PAI-1 displayed a wide distribution throughout all the connective tissue and epithelium; t-PA localized mainly in the connective tissue while PAI-2 showed little association with the connective tissue but did faintly stain in the epithelial layer. In inflamed gingival tissues, staining for t-PA was significantly increased in the extracellular matrix of the connective tissue, whereas staining for u-PA, PAT-I and PAI-2 was found to be slightly increased, but no significant difference was noted for staining when compared with the healthy gingival tissues. A granular distribution of t-PA, u-PA, PAI-1 and PAI-2 was noted around areas of inflammatory cell infiltration. These immunohistochemical findings indicate that the plasminogen activator system produced by fibroblasts may be influenced by the presence of the inflammatory mediator IL-1β. In addition, the significant increase of t-PA in inflamed connective tissue and the wide expression of these components around inflamed cells may contribute to connective tissue degradation and may relate to the migration and localization of monocytes/macrophages in inflamed tissue.     

Growth of acellular extrinsic fiber cementum (AEFC) and density of inserting fibers in human premolars of adolescents

The present study describes for the first time the changes of both AEFC thickness and the numerical density of collagen fibers inserting into AEFC at specified levels and sites of human premolars at different stages of development. The investigation was based on 45 premolars (25 maxillary, 20 mandibular; 25 first and 20 second), extracted from adolescents and young adults. All teeth were free of disease and presented with roots developed from 30-100% of their final length. They were prefixed in Karnovsky's fixative, decalcified in EDTA and subdivided into about 14 slices each, cut from mesial and distal root surfaces, vertical to and along the root axis. The slices were postfixed in OsO4, embedded in Epon and cut for light-microscopic study. AEFC thickness (4086 measurements) and the density of the collagenous fiber fringe (454 counts) inserting in AEFC were measured at 1, 3, 5 and 7 mm apical to the cementoenamel junction. The data obtained showed: AEFC thickness increased with age and varied between 0 and 57.5 microns. Between 9 and 17 years, cervical AEFC thickness increased in maxillary first premolars from an average of 5 to 30 microns, and in mandibular second premolars from 6 to 20 microns, i.e., AEFC grew at approximately the same rate as later in life. Depending on the differences in tooth development, AEFC on maxillary first premolars became thicker than that on mandibular second premolars. Due to the corono-apically decreasing gradient of AEFC development, its increase in mid-root regions lagged behind that in cervical regions of all teeth in people younger than about 14 yr.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients

Objective. There is very limited documentation available on the effects of valproate co-medication on the pharmacokinetics of aripiprazole in a naturalistic setting. The aim of the present study was to investigate the effect of co-medication with valproate on serum concentrations of aripiprazole in bipolar disorder patients in a clinical setting. Method. Plasma samples of bipolar disorder patients (n = 69) on a stable dose of aripiprazole 20 mg/day were analyzed by a liquid chromatography-mass spectrometry method in a routine therapeutic drug monitoring setting. Therapeutic drug monitoring was done for the entire study group before and after valproate co-administration. Results. We observed a statistically significant difference between the aripiprazole monotherapy and aripiprazole-valproate combination with respect to total aripiprazole plasma levels (p < 0.01). However, no statistically significant differences were noted in aripiprazole levels between the first week and the second week of valproate co-administration. Conclusion. In conclusion, concurrent treatment with valproate resulted in changes in the total aripiprazole plasma levels by 23%. But a lower total aripiprazole concentration during co-medication with valproate, caused by protein binding displacement, is reported being clinically insignificant in previous studies. The results from these studies are important in order to clarify clinical safety and efficacy.